原发性醛固酮增多症
医学
醛固酮增多症
疾病
重症监护医学
继发性高血压
醛固酮
抵抗性高血压
肾上腺切除术
内科学
血压
作者
Gian Paolo Rossi,Maurizio Cesari,Livia Lenzini,Teresa Maria Seccia
标识
DOI:10.1016/j.beem.2020.101417
摘要
Primary aldosteronism (PA) is a highly prevalent cause of arterial hypertension featuring excess cardiovascular events. A timely diagnosis and treatment of PA cures hyperaldosteronism and can provide resolution or improvement of arterial hypertension, even when the latter is resistant to drug treatment. Accordingly, strategies to screen early and widely the hypertensive patients for PA by means of simplified diagnostic algorithms are justified. Such strategies are particularly beneficial in subgroups of hypertensive patients, who are at the highest cardiovascular risk. Broadening of screening strategies means facing with an increased number of patients where monitoring the disease becomes necessary. Hence, after identification of the surgically and non surgically curable cases of PA and implementation of targeted treatment physicians are faced with the challenges of follow-up, which are scantly discussed in the literature. Hence, the purpose of this paper is to provide some recommendations on how to optimize the monitoring of patients in whom the PA subtype has been diagnosed and treatment, either with unilateral laparoscopic adrenalectomy or medically, has been instituted.
科研通智能强力驱动
Strongly Powered by AbleSci AI